163 related articles for article (PubMed ID: 23687794)
1. "Missing the target" in urothelial cancer.
Dreicer R
Oncology (Williston Park); 2013 Mar; 27(3):227, 233. PubMed ID: 23687794
[No Abstract] [Full Text] [Related]
2. Advanced urothelial carcinoma: moving the field forward.
Milowsky MI
Oncology (Williston Park); 2013 Mar; 27(3):233-4, C3. PubMed ID: 23687795
[No Abstract] [Full Text] [Related]
3. Targeted therapy in advanced urothelial carcinoma.
Verdoorn BP; Kessler ER; Flaig TW
Oncology (Williston Park); 2013 Mar; 27(3):219-26. PubMed ID: 23687793
[TBL] [Abstract][Full Text] [Related]
4. [Systemic chemotherapy of urothelial cancer].
Wolff JM; Jakse G
Urologe A; 1992 May; 31(3):W19-24. PubMed ID: 1615589
[No Abstract] [Full Text] [Related]
5. Targeted agents in second-line bladder cancer therapy.
Gerullis H; Otto T; Ecke TH
Anticancer Drugs; 2012 Nov; 23(10):1003-15. PubMed ID: 22914698
[TBL] [Abstract][Full Text] [Related]
6. Second-line systemic therapy for metastatic urothelial carcinoma of the bladder.
Ortmann CA; Mazhar D
Future Oncol; 2013 Nov; 9(11):1637-51. PubMed ID: 24156324
[TBL] [Abstract][Full Text] [Related]
7. Emerging drugs for urothelial (bladder) cancer.
Cumberbatch K; He T; Thorogood Z; Gartrell BA
Expert Opin Emerg Drugs; 2017 Jun; 22(2):149-164. PubMed ID: 28556678
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of everolimus in metastatic urothelial cancer.
Smith AB; Pruthi RS
BJU Int; 2013 Aug; 112(4):427-8. PubMed ID: 23879903
[No Abstract] [Full Text] [Related]
9. Perioperative and Maintenance Therapy After First-Line Therapy as Paradigms for Drug Discovery in Urothelial Carcinoma.
Hoffman-Censits J; Wong YN
Clin Genitourin Cancer; 2015 Aug; 13(4):302-308. PubMed ID: 25987535
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies in urothelial bladder cancer: a disappointing past preceding a bright future?
Hindy JR; Souaid T; Kourie HR; Kattan J
Future Oncol; 2019 May; 15(13):1505-1524. PubMed ID: 30977669
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients.
Salzberg M; Borner M; Bauer JA; Morant R; Rauch D; Rochlitz C
Eur J Cancer; 2006 Oct; 42(15):2660-1. PubMed ID: 16934972
[No Abstract] [Full Text] [Related]
12. Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.
Sonpavde G; Bellmunt J; Rosenberg JE; Regazzi AM; Bajorin DF; Choueiri TK; Qu AQ; Niegisch G; Albers P; Necchi A; Di Lorenzo G; Fougeray R; Wong YN; Sridhar SS; Ko YJ; Milowsky MI; Galsky MD; Pond GR
Clin Genitourin Cancer; 2014 Dec; 12(6):395-8. PubMed ID: 25035282
[No Abstract] [Full Text] [Related]
13. Making urothelial carcinomas less immune to immunotherapy.
Ramos JD; Yu EY
Urol Oncol; 2016 Dec; 34(12):534-537. PubMed ID: 27836245
[TBL] [Abstract][Full Text] [Related]
14. Current status of chemotherapy for urothelial tract tumors.
Sternberg CN; Scher HI
Oncology (Williston Park); 1987 Jul; 1(5):41-50, 60. PubMed ID: 3079483
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for advanced urothelial cancer.
Yagoda A
Semin Urol; 1983 Feb; 1(1):60-74. PubMed ID: 6382528
[No Abstract] [Full Text] [Related]
16. [Systemic chemotherapy for bladder cancer: news in 2009].
Retz M; Gschwend JE; Lehmann J
Urologe A; 2009 Jun; 48(6):655-62. PubMed ID: 19557469
[TBL] [Abstract][Full Text] [Related]
17. Intravesical chemoprophylaxis of superficial transitional cell carcinoma of the bladder. When should the drug be given?
Bouffioux C
Prog Clin Biol Res; 1985; 185B():47-55. PubMed ID: 4034591
[No Abstract] [Full Text] [Related]
18. Emerging targeted therapies for bladder cancer: a disease waiting for a drug.
Dovedi SJ; Davies BR
Cancer Metastasis Rev; 2009 Dec; 28(3-4):355-67. PubMed ID: 19997963
[TBL] [Abstract][Full Text] [Related]
19. Intracavitary treatment of transitional cell carcinoma of the bladder: questions and lessons after 27 years of experience.
Kurth KH; Sylvester R; de Pauw M; ten Kate F
Prog Clin Biol Res; 1989; 310():125-45. PubMed ID: 2672012
[No Abstract] [Full Text] [Related]
20. Bladder cancer: management of advanced disease.
Chong CD
Tex Med; 1987 Feb; 83(2):51-4. PubMed ID: 3824246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
